Back
Context Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
CNTX
Context Therapeutics, Inc.
Last Price:
$1.27
Seasonality Move:
-30%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Context Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.17 | Buy |
| 200-day SMA: | 0.88 | Buy |
| 8-day EMA: | 1.14 | Buy |
| 20-day EMA: | 1.12 | Buy |
| 50-day EMA: | 1.1 | Buy |
| 200-day EMA: | 1.03 | Buy |
Context Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 64.95 | Buy |
| Chaikin Money Flow: | 515020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.16) | Buy |
| Bollinger Bands (100): | (0.83 - 1.21) | Buy |
Context Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Context Therapeutics, Inc. Stock
Is Context Therapeutics, Inc. Stock a Buy?
-
Context Therapeutics, Inc. share price is 1.27 while CNTX 8-day simple moving average is 1.12, which is a Buy signal.
-
The stock price of CNTX is 1.27 while Context Therapeutics, Inc. 20-day SMA is 1.10, which makes it a Buy.
-
Context Therapeutics, Inc. 50-day simple moving average is 1.17 while CNTX share price is 1.27, making it a Buy technically.
-
CNTX stock price is 1.27 and Context Therapeutics, Inc. 200-day simple moving average is 0.88, creating a Buy signal.
CNTX Technical Analysis vs Fundamental Analysis
Sell
50
Context Therapeutics, Inc. (CNTX)
is a Sell
Is Context Therapeutics, Inc. a Buy or a Sell?
-
Context Therapeutics, Inc. stock is rated a SellThe current Context Therapeutics, Inc. [CNTX] share price is $1.27. The Score for CNTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Context Therapeutics, Inc. Stock Info
Market Cap:
116.7M
Price in USD:
1.27
Share Volume:
901.3K
Context Therapeutics, Inc. 52-Week Range
52-Week High:
1.55
52-Week Low:
0.49
Sell
50
Context Therapeutics, Inc. (CNTX)
is a Sell
Context Therapeutics, Inc. Share Price Forecast
-
What is the Context Therapeutics, Inc. stock price today?The Context Therapeutics, Inc. stock price is 1.27 USD today.
-
Will CNTX stock go up or go down?Context Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Context Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Context Therapeutics, Inc. is overvalued.
Is Context Therapeutics, Inc. Stock a Buy?
-
Context Therapeutics, Inc. share price is 1.27 while CNTX 8-day exponential moving average is 1.14, which is a Buy signal.
-
The stock price of CNTX is 1.27 while Context Therapeutics, Inc. 20-day EMA is 1.12, which makes it a Buy.
-
Context Therapeutics, Inc. 50-day exponential moving average is 1.10 while CNTX share price is 1.27, making it a Buy technically.
-
CNTX stock price is 1.27 and Context Therapeutics, Inc. 200-day simple moving average is 1.03, creating a Buy signal.
Fundamental Analysis of Context Therapeutics, Inc.
Is Context Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Context Therapeutics, Inc.
Should I short Context Therapeutics, Inc. stock?
-
CNTX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Context Therapeutics, Inc. is a Buy
-
Context Therapeutics, Inc. Relative Strength Index (RSI) is 64.95, which suggest Context Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Context Therapeutics, Inc. is (1.06 - 1.16), which suggest Context Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Context Therapeutics, Inc. is (0.83 - 1.21), which suggest Context Therapeutics, Inc. is a Buy
* Context Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.